{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:39:46Z","timestamp":1725583186709},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,5]]},"DOI":"10.7759\/cureus.68735","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T18:08:28Z","timestamp":1725559708000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunophenotypic Characteristics and Cytogenetic Analysis of Adolescent and Young Adult B-Cell Acute Lymphoblastic Leukemia: Correlations With Clinicopathological Parameters"],"prefix":"10.7759","author":[{"given":"Vineeta","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veeramani","family":"Raveendranath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhee","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadharshini","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhu","family":"Manivannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0156","article-title":"Acute lymphoblastic leukaemia","volume":"14","author":"Harrison CJ","year":"2001","unstructured":"Harrison CJ. Acute lymphoblastic leukaemia. Best Pract Res Clin Haematol. 2001, 14:593-607. 10.1053\/beha.2001.0156","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl S","year":"1998","unstructured":"Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood. 1998, 91:3995-4019. 10.1182\/blood.V91.11.3995","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11664","article-title":"The biology and therapy of adult acute lymphoblastic leukemia","volume":"98","author":"Faderl S","year":"2003","unstructured":"Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. Cancer. 2003, 98:1337-54. 10.1002\/cncr.11664","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.09.010","article-title":"Adult acute lymphoblastic leukemia","volume":"91","author":"Paul S","year":"2016","unstructured":"Paul S, Kantarjian H, Jabbour EJ. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2016, 91:1645-66. 10.1016\/j.mayocp.2016.09.010","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-015-0657-6","article-title":"Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden","volume":"26","author":"Katz AJ","year":"2015","unstructured":"Katz AJ, Chia VM, Schoonen WM, Kelsh MA. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control. 2015, 26:1627-42. 10.1007\/s10552-015-0657-6","journal-title":"Cancer Causes Control"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6151.1529","article-title":"Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis","volume":"2","author":"Secker-Walker LM","year":"1978","unstructured":"Secker-Walker LM, Lawler SD, Hardisty RM. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. Br Med J. 1978, 2:1529-30. 10.1136\/bmj.2.6151.1529","journal-title":"Br Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00162-5","article-title":"Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5","volume":"17","author":"Trama A","year":"2016","unstructured":"Trama A, Botta L, Foschi R. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5. Lancet Oncol. 2016, 17:896-906. 10.1016\/S1470-2045(16)00162-5","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-778530","article-title":"Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?","volume":"132","author":"Boissel N","year":"2018","unstructured":"Boissel N, Baruchel A. Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?. Blood. 2018, 132:351-61. 10.1182\/blood-2018-02-778530","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-283093","article-title":"Malignant hematologic diseases in adolescents and young adults","volume":"117","author":"Wood WA","year":"2011","unstructured":"Wood WA, Lee SJ. Malignant hematologic diseases in adolescents and young adults. Blood. 2011, 117:5803-15. 10.1182\/blood-2010-12-283093","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.04.002","article-title":"Recruitment of adolescents and young adults to cancer clinical trials--international comparisons, barriers, and implications","volume":"37","author":"Fern LA","year":"2010","unstructured":"Fern LA, Whelan JS. Recruitment of adolescents and young adults to cancer clinical trials--international comparisons, barriers, and implications. Semin Oncol. 2010, 37:e1-8. 10.1053\/j.seminoncol.2010.04.002","journal-title":"Semin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23060","article-title":"Challenges in the recruitment of adolescents and young adults to cancer clinical trials","volume":"110","author":"Burke ME","year":"2007","unstructured":"Burke ME, Albritton K, Marina N. Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer. 2007, 110:2385-93. 10.1002\/cncr.23060","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.8.1449.1449","article-title":"Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia","volume":"76","author":"Pui CH","year":"1990","unstructured":"Pui CH, Crist WM, Look T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 1990, 76:1449-83. 10.1182\/blood.V76.8.1449.1449","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3493163.x","article-title":"Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X","volume":"99","author":"Chessels JM","year":"1997","unstructured":"Chessels JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Br J Haematol. 1997, 99:93-100. 10.1046\/j.1365-2141.1997.3493163.x","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.017","article-title":"Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience","volume":"11","author":"Gupta N","year":"2019","unstructured":"Gupta N, Pawar R, Banerjee S, et al.. Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience. Mediterr J Hematol Infect Dis. 2019, 11:e2019017. 10.4084\/MJHID.2019.017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP8G5RMTWUEMUU","article-title":"Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia","volume":"132","author":"Seegmiller AC","year":"2009","unstructured":"Seegmiller AC, Kroft SH, Karandikar NJ, McKenna RW. Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia. Am J Clin Pathol. 2009, 132:940-9. 10.1309\/AJCP8G5RMTWUEMUU","journal-title":"Am J Clin Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPAN7BH5DNYWZB","article-title":"B-acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"144","author":"Loghavi S","year":"2015","unstructured":"Loghavi S, Kutok JL, Jorgensen JL. B-acute lymphoblastic leukemia\/lymphoblastic lymphoma. Am J Clin Pathol. 2015, 144:393-410. 10.1309\/AJCPAN7BH5DNYWZB","journal-title":"Am J Clin Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21518","article-title":"AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia","volume":"94","author":"Dworzak MN","year":"2018","unstructured":"Dworzak MN, Buldini B, Gaipa G, et al.. AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom. 2018, 94:82-93. 10.1002\/cyto.b.21518","journal-title":"Cytometry B Clin Cytom"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-3-16","article-title":"Childhood B-acute lymphoblastic leukemia: a genetic update","volume":"3","author":"Woo JS","year":"2014","unstructured":"Woo JS, Alberti MO, Tirado CA. Childhood B-acute lymphoblastic leukemia: a genetic update. Exp Hematol Oncol. 2014, 3:16. 10.1186\/2162-3619-3-16","journal-title":"Exp Hematol Oncol"},{"key":"ref19","article-title":"Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry [Article in Chinese]","volume":"41","author":"Shen H","year":"2003","unstructured":"Shen H, Tang Y, Yang S, Qian B, Song H. Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry [Article in Chinese]. Zhonghua Er Ke Za Zhi. 2003, 41:334-7.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1128","article-title":"Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia","volume":"102","author":"Moorman AV","year":"2003","unstructured":"Moorman AV, Richards SM, Martineau M, et al.. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood. 2003, 102:2756-62. 10.1182\/blood-2003-04-1128","journal-title":"Blood"},{"key":"ref21","article-title":"Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial","volume":"87","author":"Ribera JM","year":"2002","unstructured":"Ribera JM, Ortega JJ, Oriol A, et al.. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Haematologica. 2002, 87:154-66.","journal-title":"Haematologica"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study","volume":"111","author":"Pullarkat V","year":"2008","unstructured":"Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR. Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood. 2008, 111:2563-72. 10.1182\/blood-2007-10-116186","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman AV","year":"2007","unstructured":"Moorman AV, Harrison CJ, Buck GA, et al.. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2007, 109:3189-97. 10.1182\/blood-2006-10-051912","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12466","article-title":"Acute lymphoblastic leukemia in adolescents and young adults in Finland","volume":"93","author":"Usvasalo A","year":"2008","unstructured":"Usvasalo A, R\u00e4ty R, Knuutila S, et al.. Acute lymphoblastic leukemia in adolescents and young adults in Finland. Haematologica. 2008, 93:1161-8. 10.3324\/haematol.12466","journal-title":"Haematologica"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-232124","article-title":"A population-based cytogenetic study of adults with acute lymphoblastic leukemia","volume":"115","author":"Moorman AV","year":"2010","unstructured":"Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood. 2010, 115:206-14. 10.1182\/blood-2009-07-232124","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4236\/jct.2016.77056","article-title":"Cytogenetic profile in 7209 Indian patients with de novo acute leukemia: a single centre study from India","volume":"7","author":"Kadam Amare PS","year":"2016","unstructured":"Kadam Amare PS, Jain H, Kabre S, Deshpande Y, Pawar P. Cytogenetic profile in 7209 Indian patients with de novo acute leukemia: a single centre study from India. India Journal of Cancer Therapy. 2016, 7:530-44. 10.4236\/jct.2016.77056","journal-title":"India Journal of Cancer Therapy"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-019-01123-8","article-title":"Evaluation of cytogenetic abnormalities in patients with acute lymphoblastic leukemia","volume":"35","author":"Reddy P","year":"2019","unstructured":"Reddy P, Shankar R, Koshy T, et al.. Evaluation of cytogenetic abnormalities in patients with acute lymphoblastic leukemia. Indian J Hematol Blood Transfus. 2019, 35:640-8. 10.1007\/s12288-019-01123-8","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01460-6","article-title":"Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232","volume":"36","author":"Burke MJ","year":"2022","unstructured":"Burke MJ, Devidas M, Chen Z, et al.. Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232. Leukemia. 2022, 36:648-55. 10.1038\/s41375-021-01460-6","journal-title":"Leukemia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-015-0381-3","article-title":"Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia","volume":"9","author":"Pui CH","year":"2015","unstructured":"Pui CH. Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia. Front Med. 2015, 9:1-9. 10.1007\/s11684-015-0381-3","journal-title":"Front Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia","volume":"32","author":"Toft N","year":"2018","unstructured":"Toft N, Birgens H, Abrahamsson J, et al.. Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia. Leukemia. 2018, 32:606-15. 10.1038\/leu.2017.265","journal-title":"Leukemia"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-783852","article-title":"Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia","volume":"130","author":"Lafage-Pochitaloff M","year":"2017","unstructured":"Lafage-Pochitaloff M, Baranger L, Hunault M, et al.. Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. Blood. 2017, 130:1832-44. 10.1182\/blood-2017-05-783852","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.053","article-title":"Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials","volume":"21","author":"Boissel N","year":"2003","unstructured":"Boissel N, Auclerc MF, Lh\u00e9ritier V, et al.. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003, 21:774-80. 10.1200\/JCO.2003.02.053","journal-title":"J Clin Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403000","article-title":"Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup","volume":"17","author":"Soulier J","year":"2003","unstructured":"Soulier J, Trakhtenbrot L, Najfeld V, et al.. Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup. Leukemia. 2003, 17:1679-82. 10.1038\/sj.leu.2403000","journal-title":"Leukemia"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome","volume":"28","author":"Harrison CJ","year":"2014","unstructured":"Harrison CJ, Moorman AV, Schwab C, et al.. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia. 2014, 28:1015-21. 10.1038\/leu.2013.317","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8588(02)00004-7","article-title":"Immunophenotypic analysis of acute lymphocytic leukemia","volume":"16","author":"Riley R","year":"2002","unstructured":"Riley R, Massey D, Romagnoli G. Immunophenotypic analysis of acute lymphocytic leukemia. Hematol Oncol Clin N Am. 2002, 16:245-99. 10.1016\/s0889-8588(02)00004-7","journal-title":"Hematol Oncol Clin N Am"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10385","article-title":"Absence of prognostic impact of CD13 and\/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial","volume":"92","author":"Vitale A","year":"2007","unstructured":"Vitale A, Guarini A, Ariola C, et al.. Absence of prognostic impact of CD13 and\/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. Haematologica. 2007, 92:342-8. 10.3324\/haematol.10385","journal-title":"Haematologica"},{"key":"ref37","article-title":"Molecular-cytogenetic aberrations in B-cell adult acute lymphoblastic leukemia (B-ALL) - frequency and correlation with immunophenotype","volume":"23","author":"Velizarova M","year":"2006","unstructured":"Velizarova M, Popova D, Hadjiev E, et al.. Molecular-cytogenetic aberrations in B-cell adult acute lymphoblastic leukemia (B-ALL) - frequency and correlation with immunophenotype. Turk J Haematol. 2006, 23:151-7.","journal-title":"Turk J Haematol"},{"key":"ref38","article-title":"Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364","volume":"93","author":"Czuczman M","year":"1999","unstructured":"Czuczman M, Dodge R, Stewart C, Frankel S, Davey F. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. Blood. 1999, 93:3931-9.","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402060","article-title":"Adult precursor B-ALL with BCR\/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression","volume":"15","author":"Tabernero MD","year":"2001","unstructured":"Tabernero MD, Bortoluci AM, Alaejos I, et al.. Adult precursor B-ALL with BCR\/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression. Leukemia. 2001, 15:406-14. 10.1038\/sj.leu.2402060","journal-title":"Leukemia"},{"key":"ref40","article-title":"CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia","volume":"9","author":"Thomas X","year":"1995","unstructured":"Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia. 1995, 9:249-53.","journal-title":"Leukemia"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/135186","article-title":"Myeloid antigen expression in childhood acute lymphoblastic leukemia and its relevance for clinical outcome in indonesian ALL-2006 protocol","volume":"2012","author":"Supriyadi E","year":"2012","unstructured":"Supriyadi E, Veerman AJ, Sutaryo, Purwanto I, Vd Ven PM, Cloos J. Myeloid antigen expression in childhood acute lymphoblastic leukemia and its relevance for clinical outcome in indonesian ALL-2006 protocol. J Oncol. 2012, 2012:135186. 10.1155\/2012\/135186","journal-title":"J Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-009-0067-8","article-title":"Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome","volume":"10","author":"Bhushan B","year":"2010","unstructured":"Bhushan B, Chauhan PS, Saluja S, Verma S, Mishra AK, Siddiqui S, Kapur S. Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome. Clin Exp Med. 2010, 10:33-40. 10.1007\/s10238-009-0067-8","journal-title":"Clin Exp Med"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.47102\/annals-acadmedsg.V43N3p152","article-title":"Immunophenotypic, cytogenetic and clinical features in Chinese adult acute lymphoblastic leukaemia (ALL) patients","volume":"43","author":"Tong H","year":"2014","unstructured":"Tong H, Wang H, Wang Q, Liu Z, Lu C. Immunophenotypic, cytogenetic and clinical features in Chinese adult acute lymphoblastic leukaemia (ALL) patients. Ann Acad Med Singap. 2014, 43:152-9.","journal-title":"Ann Acad Med Singap"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/0925-5710(94)00348-i","article-title":"CD33+B-cell precursor acute lymphoblastic leukemia in children: adistinct subgroup of B-cell precursor acute lymphoblastic leukemia","volume":"61","author":"Hara J","year":"1995","unstructured":"Hara J, Hosoi G, Okamura T. CD33+B-cell precursor acute lymphoblastic leukemia in children: adistinct subgroup of B-cell precursor acute lymphoblastic leukemia. Inj J Hematol. 1995, 61:77-84. 10.1016\/0925-5710(94)00348-i","journal-title":"Inj J Hematol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9545717","article-title":"Clinical impact of CD25\/CD123 coexpression in adult b-cell acute lymphoblastic leukemia patients","volume":"2020","author":"Aref S","year":"2020","unstructured":"Aref S, El Agdar M, Khaled N, Ibrahim L, El-Ghonemy MS. Clinical impact of CD25\/CD123 coexpression in adult b-cell acute lymphoblastic leukemia patients. Adv Hematol. 2020, 2020:9545717. 10.1155\/2020\/9545717","journal-title":"Adv Hematol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.7.2115","article-title":"Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia","volume":"97","author":"Chen JS","year":"2001","unstructured":"Chen JS, Coustan-Smith E, Suzuki T, Neale GA, Mihara K, Pui CH, Campana D. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood. 2001, 97:2115-20. 10.1182\/blood.v97.7.2115","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324004","article-title":"New markers for minimal residual disease detection in acute lymphoblastic leukemia","volume":"117","author":"Coustan-Smith E","year":"2011","unstructured":"Coustan-Smith E, Song G, Clark C, et al.. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011, 117:6267-76. 10.1182\/blood-2010-12-324004","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2018.03.005","article-title":"Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia","volume":"475","author":"S\u0119dek \u0141","year":"2019","unstructured":"S\u0119dek \u0141, Theunissen P, Sobral da Costa E, et al.. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia. J Immunol Methods. 2019, 475:112429. 10.1016\/j.jim.2018.03.005","journal-title":"J Immunol Methods"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21486","article-title":"Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000","volume":"94","author":"Tembhare PR","year":"2018","unstructured":"Tembhare PR, Ghogale S, Ghatwai N, et al.. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000. Cytometry B Clin Cytom. 2018, 94:100-11. 10.1002\/cyto.b.21486","journal-title":"Cytometry B Clin Cytom"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.000299","article-title":"Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia","volume":"94","author":"Djokic M","year":"2009","unstructured":"Djokic M, Bj\u00f6rklund E, Blennow E, Mazur J, S\u00f6derh\u00e4ll S, Porwit A. Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia. Haematologica. 2009, 94:1016-9. 10.3324\/haematol.2008.000299","journal-title":"Haematologica"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-017-0845-5","article-title":"Evaluating new markers for minimal residual disease analysis by flow cytometry in precursor B lymphoblastic leukemia","volume":"34","author":"Jain S","year":"2018","unstructured":"Jain S, Mehta A, Kapoor G, et al.. Evaluating new markers for minimal residual disease analysis by flow cytometry in precursor B lymphoblastic leukemia. Indian J Hematol Blood Transfus. 2018, 34:48-53. 10.1007\/s12288-017-0845-5","journal-title":"Indian J Hematol Blood Transfus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/284355-immunophenotypic-characteristics-and-cytogenetic-analysis-of-adolescent-and-young-adult-b-cell-acute-lymphoblastic-leukemia-correlations-with-clinicopathological-parameters","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T18:08:36Z","timestamp":1725559716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/284355-immunophenotypic-characteristics-and-cytogenetic-analysis-of-adolescent-and-young-adult-b-cell-acute-lymphoblastic-leukemia-correlations-with-clinicopathological-parameters"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.68735","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}